MUMBAI : Pharmaceuticals manufacturer Ipca Laboratories Ltd posted a 20% rise in its total Income at ₹4432.12 crore for the financial year 2020 against ₹3687.74 crore in the previous fiscal on a standalone basis, it said in a regulatory filing.Ipca, recorded a 43% year-on-year (y-o-y) jump in net standalone profit at ₹652.46 crore in FY20 as against ₹454.91 crore in FY19.
On a consolidated basis, its profit rose by 36% to ₹603.56 crore.The company which has seven subsidiaries and seven other related entities recorded a 23% jump in net total income at ₹4715.71 crore on a consolidated basis for FY2020.“Being manufacturers of pharmaceuticals, the operations of the company were exempted from lockdown declared by both the Central and State.